Dr Karthik Ramasamy has established a strong myeloma and other plasma cell dyscrasias clinical practice in Oxford. He is the Lead Clinician for myeloma and other plasma dyscrasias in Thames Valley Strategic Clinical Network. He is a Chief Investigator of national myeloma studies and Principal Investigator of a number of myeloma trials.
Dr Ramasamy has recently been appointed as Divisional Lead of Cancer Research across Thames Valley and South Midlands Research Network.
Current NHS post
Consultant Haematologist, Oxford University Hospitals NHS Trust
Member, National Cancer Research Institute.
Myeloma Studies Group.
MCTN Meyeloma UK.
Exec, UK Myeloma Forum.
Member, American Society for Haematology.
Member, British Society of Haematology.
Member, British Society of Bone and Marrow Transplantation.